VolitionRx (VNRX) Stock Chart & Stock Price History → Elon Musk Secret Crypto Plot Exposed (From Crypto 101 Media) (Ad) Free VNRX Stock Alerts $0.74 +0.02 (+2.79%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media VolitionRx Stock Price Performance5 Day Performance-17.39%1 Month Performance+0.84%3 Month Performance-37.63%6 Month Performance-14.42%Year-To-Date Performance+2.65% Receive VNRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for VolitionRx and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. VNRX Stock Chart for Wednesday, May, 8, 2024 VNRX Chart by TradingView VolitionRx Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$0.72$0.74+2.22%$0.82$0.72173,718 shs$60.40 million05/07/2024$0.78$0.72-7.61%$0.81$0.72304,804 shs$59.09 million05/06/2024$0.89$0.78-12.53%$0.89$0.78170,234 shs$63.96 million05/03/2024$0.88$0.89+1.43%$0.91$0.85107,874 shs$73.12 million05/02/2024$0.87$0.88+1.42%$0.91$0.8778,163 shs$72.08 million05/01/2024$0.90$0.87-3.77%$0.91$0.84142,260 shs$71.07 million Get the Latest News and Ratings for VNRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VolitionRx and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$0.86$0.90+4.66%$0.95$0.8477,449 shs$73.86 million04/29/2024$0.91$0.86-5.90%$0.90$0.8293,069 shs$70.56 million04/26/2024$0.89$0.91+2.65%$0.93$0.86208,977 shs$74.99 million04/25/2024$0.80$0.89+11.27%$1.02$0.78485,739 shs$73.06 million04/24/2024$0.85$0.80-5.88%$0.86$0.78347,148 shs$65.66 million04/23/2024$0.60$0.85+41.10%$0.88$0.613.39 million shs$69.76 million04/22/2024$0.62$0.60-2.21%$0.61$0.5951,117 shs$49.44 million04/19/2024$0.62$0.62+1.00%$0.65$0.57245,613 shs$51.16 million04/18/2024$0.60$0.62+2.87%$0.65$0.60255,788 shs$50.65 million04/17/2024$0.62$0.60-2.44%$0.65$0.59172,749 shs$49.24 million04/16/2024$0.68$0.62-9.40%$0.66$0.61138,511 shs$50.47 million04/15/2024$0.69$0.68-0.91%$0.71$0.66130,511 shs$55.71 million04/12/2024$0.71$0.69-3.51%$0.74$0.69103,785 shs$56.22 million04/11/2024$0.72$0.71-1.69%$0.75$0.7090,165 shs$58.26 million04/10/2024$0.76$0.72-4.99%$0.76$0.7180,481 shs$59.26 million04/09/2024$0.73$0.76+4.12%$0.76$0.7355,648 shs$62.37 million04/08/2024$0.75$0.73-2.38%$0.75$0.7230,635 shs$59.90 million04/05/2024$0.76$0.75-1.49%$0.76$0.72162,119 shs$61.36 million04/04/2024$0.76$0.76+0.48%$0.78$0.7446,395 shs$62.29 million04/03/2024$0.77$0.76-2.52%$0.78$0.7595,895 shs$61.99 million04/02/2024$0.77$0.77+0.10%$0.78$0.7583,436 shs$63.60 million04/01/2024$0.76$0.77+2.26%$0.79$0.7648,520 shs$63.53 million03/29/2024$0.77$0.76-1.06%$0.79$0.73287,763 shs$62.13 million03/28/2024$0.73$0.77+4.81%$0.79$0.73287,763 shs$62.79 million03/27/2024$0.75$0.73-2.64%$0.76$0.70574,128 shs$57.44 million03/26/2024$0.72$0.75+4.14%$0.84$0.74467,174 shs$59.00 million03/25/2024$0.73$0.72-1.73%$0.80$0.70134,954 shs$56.66 million03/22/2024$0.73$0.73+0.36%$0.77$0.73200,981 shs$57.65 million03/21/2024$0.81$0.73-9.88%$0.83$0.73185,069 shs$57.44 million03/20/2024$0.85$0.81-4.71%$0.87$0.80188,270 shs$63.74 million03/19/2024$0.87$0.85-2.55%$0.89$0.8585,607 shs$66.89 million03/18/2024$0.96$0.87-9.15%$0.97$0.8766,482 shs$68.63 million03/15/2024$0.90$0.96+6.67%$0.96$0.89126,156 shs$75.54 million03/14/2024$0.99$0.90-8.96%$0.96$0.8971,245 shs$70.82 millionFidelity, Bezos, Goldman Bet Big on Tiny Biotech (Ad)Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>>03/13/2024$0.99$0.99-0.07%$1.02$0.9681,289 shs$77.79 million03/12/2024$1.06$0.99-6.67%$1.09$0.95103,825 shs$77.85 million03/11/2024$1.02$1.06+3.92%$1.10$0.9762,266 shs$83.41 million03/08/2024$0.99$1.01+2.02%$1.01$0.9677,525 shs$79.48 million03/07/2024$0.99$0.99-0.40%$1.00$0.9428,852 shs$77.90 million03/06/2024$0.87$0.99+14.25%$1.00$0.8850,164 shs$78.22 million03/05/2024$1.01$0.87-13.86%$1.01$0.86214,150 shs$68.46 million03/04/2024$1.04$1.01-2.88%$1.04$0.9788,114 shs$79.47 million03/01/2024$0.98$1.04+5.68%$1.05$0.9833,376 shs$81.84 million02/29/2024$0.99$0.98-0.96%$1.02$0.9822,047 shs$77.44 million02/28/2024$0.99$0.99+0.33%$1.02$0.9823,762 shs$78.19 million02/27/2024$0.98$0.99+1.30%$1.02$0.9629,021 shs$77.93 million02/26/2024$1.04$0.98-6.00%$1.02$0.95109,539 shs$76.93 million02/23/2024$0.97$1.04+7.15%$1.04$0.9571,867 shs$81.84 million02/22/2024$0.97$0.97+0.04%$0.99$0.9475,430 shs$76.38 million02/21/2024$1.05$0.97-7.60%$1.08$0.92201,942 shs$76.35 million02/20/2024$1.04$1.05+0.96%$1.08$1.0347,360 shs$82.62 million02/19/2024$1.04$1.04$1.11$1.0439,100 shs$81.83 million02/16/2024$1.08$1.04-3.70%$1.11$1.0439,106 shs$81.84 million02/15/2024$1.07$1.08+0.93%$1.10$1.0439,620 shs$84.98 million02/14/2024$1.03$1.07+3.88%$1.11$1.0297,588 shs$84.20 million02/13/2024$1.08$1.03-4.63%$1.10$1.0275,151 shs$81.05 million02/12/2024$1.13$1.08-4.42%$1.17$1.08197,924 shs$84.99 million02/09/2024$1.18$1.13-4.24%$1.15$1.09125,360 shs$88.92 million02/08/2024$1.19$1.18-0.84%$1.22$1.13106,481 shs$92.85 million02/07/2024$1.13$1.19+5.31%$1.19$1.08105,887 shs$93.64 million Related Companies: TKNO Stock Price Chart ABIO Stock Price Chart AWH Stock Price Chart ICCC Stock Price Chart OCX Stock Price Chart ACHV Stock Price Chart TIL Stock Price Chart DTIL Stock Price Chart DERM Stock Price Chart ASMB Stock Price Chart Receive VNRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for VolitionRx and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:VNRX) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressCharles Payne Demystifies OptionsUnstoppable ProsperityGold Set to EXPLODE!Gold Safe ExchangeThe AI Stock that’s Disrupting Every IndustryStockEarningsShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.